While alterations like EGFR and ALK are rare in LCNEC since these are primarily smoking-associated tumors, KRAS G12C mutations have a similar prevalence to that in adenocarcinoma (~13%)22. Here, KRAS is linked to large cell neuroendocrine carcinoma.